Interní Med. 2010; 12(6): 308-311

Familial combined hyperlipidemia

MUDr.David Karásek, Ph.D.1, prof.MUDr.Helena Vaverková, CSc.1, MUDr.Dagmar Jackuliaková1, doc.MUDr.Zdeněk Fryšák, CSc.1, MUDr.Milan Halenka, Ph.D.1, MUDr.Dalibor Pastucha, Ph.D.2
1 III. interní klinika LF UP a FN Olomouc
2 Klinika tělovýchovného lékařství a kardiovaskulární rehabilitace, FN a LF UP Olomouc

Familial combined hyperlipidemia is the most common genetic hyperlipidemia with a high risk of early atherosclerosis manifestation.

Authors of the review present current knowledge concerning to prevalence, etiology, pathogenesis, laboratory findings, diagnostic

criteria, clinical manifestation and management of familial combined hyperlipidemia.

Keywords: familial combined hyperlipidemia, apolipoprotein B, insulin resistance, metabolic syndrome

Published: July 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Karásek D, Vaverková H, Jackuliaková D, Fryšák Z, Halenka M, Pastucha D. Familial combined hyperlipidemia. Interní Med. 2010;12(6):308-311.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Šimon J, a kol. Epidemiologie a prevence ischemické choroby srdeční. Praha: Grada Publishing 2001: 264 s.
    2. Češka R, a kol. Cholesterol a ateroskleróza, léčba dyslipidemií. Praha: Triton 2005, 343 s.
    3. Gaddi A, Galetti C, Pauciullo P, et al. Familial combined hyperlipoproteinemia: experts panel position on diagnostic criteria for clinical practice. Committee of experts of the Atherosclerosis and Dysmetabolic Disorders Study Group. Nutr Metab Cardiovasc Dis 1999; 9: 304-311.
    4. Gaddi A, Cicero AF, Odoo FO, et al. Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date. Vasc Health Risk Manag 2007; 3: 877-886. Go to PubMed...
    5. Goldstein JL, Schrott HG, Hazzard WR, et al. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a now inherited disorder, combined hyperlipidemia. J Clin Invest 1973; 52: 1544-1568. Go to original source... Go to PubMed...
    6. Hokanson JE, Austin MA, Zambon A, et al. Plasma triglyceride and LDL heterogenity in familial combined hyperlipidemia. Arteriocler Thromb 1993; 13: 427-434. Go to original source... Go to PubMed...
    7. Vaverková H, Weinbergová O, Horčička V, et al. Rodinná kombinovaná hyperlipidemie I. Rozmanitost lipoproteinového obrazu. Vnitř Lék 1986; 32: 878-886. Go to PubMed...
    8. Keulen ETP, Voors-Pette C, de Bruin TWA. Familial dyslipidemic hypertension syndrome: Familial combined hyperlipidemia, and the role of abdominal fat mass. Am J Hypertens 2001; 14: 357-363. Go to original source... Go to PubMed...
    9. Jackuliaková D, Vaverková H, Karásek D. Vztah mezi familiární kombinovanou hyperlipidemií a inzulínovou rezistencí. Vnitř Lék 2008; 54: 1045-1053. Go to PubMed...
    10. de Graaf J, Stalenhoef AF. Defects of lipoprotein metabolism in familial combined hyperlipidemia. Curr Opin Lipidol 1998; 9: 189-196. Go to original source... Go to PubMed...
    11. Vaverková H, Novotný D, Karásek D, et al. Familiární kombinovaná hyperlipidemie: asociace s dalšími rizikovými faktory aterosklerózy. DMEV 2005; (suppl 3/8): 5-11.
    12. Venkatesan S, Cullen P, Pacy P, et al. Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia. Arterioscler Thromb 1993; 13: 110-118. Go to original source... Go to PubMed...
    13. Evans K, Burdge GC, Wootton SA, et al. Tissue-specific stable isotope measurements of postprandial lipid metabolism in familial combined hyperlipidaemia. Atherosclerosis 2008; 197: 164-170. Go to original source... Go to PubMed...
    14. Campagna F, Montali A, Baroni MG, et al. Common variants in the lipoprotein lipase gene, but not those in the insulin receptor substrate-1, the beta3-adrenergic receptor, and the intestinal fatty acid binding protein-2 genes, influence the lipid phenotypic expression in familial combined hyperlipidemia. Metabolism 2002; 51: 1298-1305. Go to original source... Go to PubMed...
    15. Babirak SP, Brown BG, Brunzell JD. Familial combined hyperlipidemia and abnormal lipoprotein lipase. Arterioscler Thromb 1992; 12: 1176-1183. Go to original source... Go to PubMed...
    16. Cullen P, Farren B, Scott J, et al. Complex segregation analysis provides evidence for a major gene acting on serum triglyceride levels in 55 British families with familial combined hyperlipidemia. Arterioscler Thromb 1994; 14: 1233-1249. Go to original source... Go to PubMed...
    17. Aouizerat BE, Allayee H, Bondar J, et al. Novel genes for familial combined hyperlipidemia. Curr Opin Lipidol 1999; 10: 113-122. Go to original source... Go to PubMed...
    18. Castellani L, Weinreb A, Bodnar J, et al. Mapping a gene for combined hyperlipidaemia in a mutant mouse strain. Nat Genet 1998; 18: 374-377. Go to original source... Go to PubMed...
    19. Aouizerat BE, Allayee H, Cantor RM, et al. Linkage of a candidate gene locus to familial combined hyperlipidemia: lecithin: cholesterol acyltransferase on 16q. Arterioscler Thromb Vasc Biol 1999; 19: 2730-2736. Go to original source... Go to PubMed...
    20. Pihlajamäki J, Karjalainen L, Karhapää P, et al. G-250A substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 2000; 20: 1789-1795. Go to original source... Go to PubMed...
    21. Pajukanta P, Lilja HE, Sinsheimer JS, et al. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nat Genet 2004; 36: 371-376. Go to original source... Go to PubMed...
    22. Sniderman AD, Castro Cabezas M, Ribalta J, et al. A proposal to redefine familial combined hyperlipidaemia - third workshop on FCHL held in Barcelona from 3 to 5 May 2001, during the scientific sessions of the European Society for Clinical Investigation. Eur J Clin Invest 2002; 32: 71-73. Go to original source... Go to PubMed...
    23. Veerkamp MJ, de Graaf J, Bredie SJ, et al. Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow. Arterioscler Thromb Vasc Biol 2002; 22: 274-282. Go to original source... Go to PubMed...
    24. Lamarche B, Després JP, Moorjani S, et al. Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Québec Cardiovascular Study). Am J Cardiol 1995; 75: 1189-1195. Go to original source... Go to PubMed...
    25. Demacker PN, Veerkamp MJ, Bredie SJ, et al. Comparison of the measurement of lipids and lipoproteins versus assay of apolipoprotein B for estimation of coronary heart disease risk: a study in familial combined hyperlipidemia. Atherosclerosis 2000; 153: 483-490. Go to original source... Go to PubMed...
    26. Veerkamp MJ, de Graaf J, Hendriks JC, et al. Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study. Circulation 2004; 109: 2980-2985. Go to original source... Go to PubMed...
    27. Skoumas I, Masoura C, Pitsavos C, et al. Evidence that nonlipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia. Int J Cardiol 2007; 121: 178-183. Go to original source... Go to PubMed...
    28. Halenka M, Vaverkova H, Hutyra M, et al. Detection of early atherosclerosis using the ultrasound parameter of the intima-media thickness of the common carotid artery in families with familial combined hyperlipidemia. Int Angiol 2004; 23: 230-237. Go to PubMed...
    29. Keulen ET, Kruijshoop M, Schaper NC, et al. Increased intima-media thickness in familial combined hyperlipidemia associated with apolipoprotein B. Arterioscler Thromb Vasc Biol 2002; 22: 283-288. Go to original source... Go to PubMed...
    30. Karásek D, Vaverková H, Halenka M, et al. Brachial endothelial function in subjects with familial combined hyperlipidemia and its relationships to carotid artery intima-media thickness. Int Angiol 2006; 25: 418-426. Go to PubMed...
    31. Karásek D, Vaverková H, Halenka M, et al. Endothelial haemostatic markers in members of families with familial combined hyperlipidemia. Thromb Res 2009; 123: 466-475. Go to original source... Go to PubMed...
    32. Vaverková H, Soška H, Rosolová, et al. Doporučení pro diagnostiku a léčbu dyslipidemií v dospělosti vypracované výborem České společnosti pro aterosklerózu. Cor Vasa 2007; (Suppl. 11/49): 47-60.
    33. Tenenbaum A, Fisman EZ, Motro M, et al. Optimal management of combined dyslipidemia: what have we behind statins monotherapy? Adv Cardiol 2008; 45: 127-153. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.